This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

AI identifies antimalarial drug as possible osteoporosis treatment

AI identifies antimalarial drug as possible osteoporosis treatment
Osteoporotic mice treated with dihydroartemisinin (DHA) had significantly improved bone density (bottom) compared to controls (top). Credit: Adapted from ACS Central Science, 2023, DOI: 10.1021/acscentsci.3c00794

Artificial intelligence has exploded in popularity and is being harnessed by some scientists to predict which molecules could treat illnesses, or to quickly screen existing medicines for new applications.

Researchers reporting in ACS Central Science have used one such deep learning algorithm, and found that dihydroartemisinin (DHA), an antimalarial drug and derivative of a traditional Chinese medicine, could treat osteoporosis as well. The team showed that in mice, DHA effectively reversed osteoporosis-related .

In healthy people, there is a balance between the osteoblasts that build new bone and osteoclasts that break it down. But when the "demolition crew" becomes overactive, it can result in bone loss and a disease called osteoporosis, which typically affects older adults.

Current treatments for osteoporosis primarily focus on slowing the activity of osteoclasts. But osteoblasts—or more specifically, their precursors known as (BMMSCs)—could be the basis for a different approach. During osteoporosis, these multipotent cells tend to turn into fat-creating cells instead, but they could be reprogrammed to help treat the disease.

Previously, Zhengwei Xie and colleagues developed a deep learning algorithm that could predict how effectively certain small-molecule drugs reversed changes to associated with the disease. This time, joined by Yan Liu and Weiran Li, they wanted to use the algorithm to find a new treatment strategy for osteoporosis that focused on BMMSCs.

The team ran the program on a profile of differently expressed genes in newborn and adult mice. One of the top-ranked compounds identified was DHA, a derivative of artemisinin and a key component of malaria treatments. Administering DHA extract for six weeks to mice with induced osteoporosis significantly reduced bone loss in their femurs and nearly completely preserved bone structure. To improve delivery, the team designed a more robust system using injected, DHA-loaded nanoparticles.

Bones of mice with osteoporosis that received the treatment were similar to those of the , and the treatment showed no evidence of toxicity. In further tests, the team determined that DHA interacted with BMMSCs to maintain their stemness and ultimately produce more osteoblasts. The researchers say that this work demonstrates that DHA is a promising therapeutic agent for osteoporosis.

More information: Deep Learning-Predicted Dihydroartemisinin Rescues Osteoporosis by Maintaining Mesenchymal Stem Cell Stemness through Activating Histone 3 Lys 9 Acetylation, ACS Central Science (2023). DOI: 10.1021/acscentsci.3c00794

Journal information: ACS Central Science
Citation: AI identifies antimalarial drug as possible osteoporosis treatment (2023, October 18) retrieved 20 February 2024 from https://medicalxpress.com/news/2023-10-ai-antimalarial-drug-osteoporosis-treatment.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Researchers identify protein that may help protect against osteoporosis

63 shares

Feedback to editors